 |
The Journal of Neuroscience, December 8, 2004, 24(49):11165-11170; doi:10.1523/JNEUROSCI.2559-04.2004
Previous Article | Next Article 
Neurobiology of Disease
Role of -Synuclein in Presynaptic Dopamine Recruitment
Leonid Yavich,1,2
Heikki Tanila,2,4
Saila Vepsäläinen,2,3 and
Pekka Jäkälä2,4
Departments of 1Pharmacology and Toxicology and 2Neuroscience and Neurology and 3Brain Research Unit, Clinical Research Centre/Mediteknia, University of Kuopio, and 4Department of Neurology, University Hospital of Kuopio, FIN-70211 Kuopio, Finland
Real-time monitoring of stimulated dopamine release in mice with different -synuclein expression was used to study the role of -synuclein in presynaptic dopamine recruitment. Repeated electrical stimulations of ascending dopaminergic pathways decreased the capacity of the readily releasable pool (RRP) and temporarily increased its refilling rate, significantly slowing the rate of dopamine decline in mice with normally expressed -synuclein. Mice with -synuclein null mutation demonstrated a permanent increase of the refilling rate. This increase maintained stable dopamine release during stimulation (which induced dopamine decline in other animals) and served as an adaptation to altered dopamine compartmentalization. Mice without -synuclein and with overexpression of human A30P mutated -synuclein had a lower capacity of the dopamine storage pool than other animals. Reducing capacity of the storage pool in transgenic A30P mice led to paradoxical effects of L-dopa, which elevated dopamine release in response to single stimulation but decreased the refilling rate of the RRP.
Key words: dopamine; storage; -synuclein; null mutation; A30P transgenic mice; in vivo voltammetry
Received June 28, 2004;
revised October 17, 2004;
accepted October 20, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
J. D. Perlmutter, A. R. Braun, and J. N. Sachs
Curvature Dynamics of {alpha}-Synuclein Familial Parkinson Disease Mutants: MOLECULAR SIMULATIONS OF THE MICELLE- AND BILAYER-BOUND FORMS
J. Biol. Chem.,
March 13, 2009;
284(11):
7177 - 7189.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bisaglia, S. Mammi, and L. Bubacco
Structural insights on physiological functions and pathological effects of {alpha}-synuclein
FASEB J,
February 1, 2009;
23(2):
329 - 340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
O. S. Gorbatyuk, S. Li, L. F. Sullivan, W. Chen, G. Kondrikova, F. P. Manfredsson, R. J. Mandel, and N. Muzyczka
The phosphorylation state of Ser-129 in human {alpha}-synuclein determines neurodegeneration in a rat model of Parkinson disease
PNAS,
January 15, 2008;
105(2):
763 - 768.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Thomas and M. F. Beal
Parkinson's disease
Hum. Mol. Genet.,
October 15, 2007;
16(R2):
R183 - R194.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. E. Larsen, Y. Schmitz, M. D. Troyer, E. Mosharov, P. Dietrich, A. Z. Quazi, M. Savalle, V. Nemani, F. A. Chaudhry, R. H. Edwards, et al.
{alpha}-Synuclein Overexpression in PC12 and Chromaffin Cells Impairs Catecholamine Release by Interfering with a Late Step in Exocytosis.
J. Neurosci.,
November 15, 2006;
26(46):
11915 - 11922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. L. Fortin, V. M. Nemani, S. M. Voglmaier, M. D. Anthony, T. A. Ryan, and R. H. Edwards
Neural Activity Controls the Synaptic Accumulation of {alpha}-Synuclein
J. Neurosci.,
November 23, 2005;
25(47):
10913 - 10921.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-J. Lee, S. Patel, and S.-J. Lee
Intravesicular Localization and Exocytosis of {alpha}-Synuclein and its Aggregates
J. Neurosci.,
June 22, 2005;
25(25):
6016 - 6024.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ziolkowska, A. Gieryk, W. Bilecki, A. Wawrzczak-Bargiela, K. Wedzony, A. Chocyk, P. E. Danielson, E. A. Thomas, B. S. Hilbush, J. G. Sutcliffe, et al.
Regulation of {alpha}-Synuclein Expression in Limbic and Motor Brain Regions of Morphine-Treated Mice
J. Neurosci.,
May 18, 2005;
25(20):
4996 - 5003.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|